Patient characteristics pre and post-implementation of an antifungal risk-based algorithm
There were no significant differences in sex, race, ethnicity, or cancer diagnosis between patients diagnosed before or after algorithm implementation, nor did we observe any change in patterns of IMI timing (in first remission vs. relapse, age at IMI diagnosis, Table 1 ). Host and clinical risk factors known to be associated with risk for IMI were also largely unchanged between the two time periods (Table 3 ), except that patients treated more recently were more likely to be admitted to the intensive care unit (p=0.003).